Tower Research Capital (TRC)’s ProShares UltraShort Health Care RXD Stock Holding History

Tower Research Capital (TRC)’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$11	–	5525
2025 Q3	$11	Buy	+1	New	+$24	﹤0.01%	5179
2017 Q1	–	Sell	-2	Closed	–	–	3794
2016 Q4	$0	Buy	+2	New	+$373	﹤0.01%	4317
2016 Q3	–	Sell	-5	Closed	-$1K	–	4320
2016 Q2	$1K	Buy	+5	New	+$963	﹤0.01%	4204
2016 Q1	–	Sell	-19	Closed	-$4K	–	4811
2015 Q4	$4K	Buy	19 +17	+850%	+$3.46K	﹤0.01%	3244
2015 Q3	$1K	Buy	+2	New	+$403	﹤0.01%	3668

Other funds holding RXD

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s RXD Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of ProShares UltraShort Health Care (RXD) in Q4 2025, closing a stake of 1 share — an estimated $11 sold.

Tower Research Capital (TRC) first reported a position in RXD in Q3 2015 and held it in 5 quarters. The position peaked at $4K in Q4 2015. 3 funds tracked by Wall St. Rank hold RXD as of Q4 2025.

Tower Research Capital (TRC) reported no remaining ProShares UltraShort Health Care position as of Q4 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 1 ProShares UltraShort Health Care share in Q4 2025, an estimated $11.
Tower Research Capital (TRC) first reported a position in ProShares UltraShort Health Care in Q3 2015 and held it in 5 quarters.
Tower Research Capital (TRC)'s ProShares UltraShort Health Care position peaked at $4K in Q4 2015.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.